NO ADJUVANT CHEMOTHERAPY IN SELECTED PATIENTS WITH PATHOLOGIC STAGE-II NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS

被引:54
作者
PIZZOCARO, G
MONFARDINI, S
机构
关键词
D O I
10.1016/S0022-5347(17)50575-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:677 / 680
页数:4
相关论文
共 21 条
[1]  
EINHORN LH, 1980, CANCER, V46, P1339, DOI 10.1002/1097-0142(19800915)46:6<1339::AID-CNCR2820460607>3.0.CO
[2]  
2-J
[3]  
EINHORN LH, 1981, ADJUVANT THERAPY CAN, V3, P17
[4]  
PIZZOCARO G, 1981, EUR UROL, V7, P1
[5]  
PIZZOCARO G, 1982, P AM SOC CLIN ONCOL, V1, P121
[6]   ADJUVANT THERAPY OF TESTIS CANCER - THE ROLE OF VINBLASTINE AND BLEOMYCIN [J].
SAMUELS, ML ;
JOHNSON, DE .
JOURNAL OF UROLOGY, 1980, 124 (03) :369-371
[7]  
SAMUELS ML, 1975, CANCER CHEMOTH REP 1, V59, P563
[8]  
SANFILIPPO O, 1983, 13 P INT C CHEM VIEN, P291
[9]   RELEVANCE OF BIOCHEMICAL TUMOR-MARKERS AND LYMPHADENECTOMY IN MANAGEMENT OF NON-SEMINOMATOUS TESTIS TUMORS - CURRENT PERSPECTIVE [J].
SKINNER, DG ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1980, 123 (03) :378-382
[10]  
STAUBITZ WJ, 1973, CANCER-AM CANCER SOC, V32, P1206, DOI 10.1002/1097-0142(197311)32:5<1206::AID-CNCR2820320529>3.0.CO